Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
Just now	Adyton Resources Announces Filing of Financial Statements and MD&A for the Three Months Ending March 31, 2026
Just now	BluMetric Announces Q2 2026 Financial Results
1m ago	ComEd Renewable Energy Investments Help Expand Customer Access to Clean Energy and Lower Costs
1m ago	Avis Budget Group Announces Pricing of $300 Million of Senior Notes
1m ago	NexMetals Announces Results of Annual General Meeting of Shareholders

About

0.22USD-0.01 -3.44%

Closed • Updated at 21:39 GMT+00:00

Market Cap$4.37M

Volume3.30M

Beta3.22

RSI54.21

Gross Margin-14976.66%

FinanceFinancial Conglomerates

Virax Biolabs Group Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Virax Biolabs Group Limited Announces $5 Million Private Placement

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Recent Videos

VRAX Stock TOMORROW UPDATE! (The Exact Answer!) Virax Biolabs

VRAX Stock TOMORROW UPDATE! (The Exact Answer!) Virax Biolabs

May 26, 2026

VRAX Surges 148% Premarket: Virax Biolabs Targets Post-Viral Diagnostics

VRAX Surges 148% Premarket: Virax Biolabs Targets Post-Viral Diagnostics

May 20, 2026

VRAX Surges 148% Premarket: Virax Biolabs Targets Post-Viral Diagnostics

VRAX Surges 148% Premarket: Virax Biolabs Targets Post-Viral Diagnostics

May 20, 2026

Virax Biolabs (VRAX): A Potential First-in-Category Diagnostic for Long COVID & Lyme Disease ME/CFS

Virax Biolabs (VRAX): A Potential First-in-Category Diagnostic for Long COVID & Lyme Disease ME/CFS

May 20, 2026

Community Chat

Ask AI

Try asking